Benjamin A. Y. Cher

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Syed Nabeel Zafar · 4 shared papers, 2026 · strength 1.20
   • Paper Assessing the Evidence for Neoadjuvant Chemotherapy in Patients with Resectable Pancreatic Adenocarcinoma Using the Rob… DOI 10.1245/s10434-026-19443-1↗
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
2. Clayton Thomas Marcinak · 3 shared papers, 2026 · strength 0.87
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
   • Paper ASO Visual Abstract: Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pa… DOI 10.1245/s10434-026-20507-5↗
3. Muhammad Maisam Ali · 3 shared papers, 2026 · strength 0.87
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
   • Paper ASO Visual Abstract: Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pa… DOI 10.1245/s10434-026-20507-5↗
4. Noelle K. LoConte · 2 shared papers, 2026 · strength 0.58
   • Paper Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pancreatic Ductal Adeno… DOI 10.1245/s10434-026-20419-4↗
   • Paper ASO Visual Abstract: Association of Social Determinants of Health with Delays in Diagnosis and Treatment of Resected Pa… DOI 10.1245/s10434-026-20507-5↗
5. Sharon Marie Weber · 2 shared papers, 2025–2026 · strength 0.53
   • Paper Assessing the Evidence for Neoadjuvant Chemotherapy in Patients with Resectable Pancreatic Adenocarcinoma Using the Rob… DOI 10.1245/s10434-026-19443-1↗
   • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
6. Alexandra W. Acher · 1 shared paper, 2026 · strength 0.29
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
7. Jeremy D. Kratz · 1 shared paper, 2026 · strength 0.29
   • Paper Driver mutation profiling by next-generation sequencing predicts survival and recurrence after curative-intent resectio… DOI 10.1007/s12094-026-04564-6↗
8. Alexander A. Parikh · 1 shared paper, 2025 · strength 0.19
   • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
9. Daniel Erik Abbott · 1 shared paper, 2025 · strength 0.19
   • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
10. Syed Ameen Ahmad · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
11. Rebecca Anne Snyder · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
12. Nipun B. Merchant · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
13. Sameer H. Patel · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
14. Mihir Maheshkumar Shah · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
15. Chet W. Hammill · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
16. Jashodeep Datta · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
17. Charles Raben Scoggins · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
18. Shishir Kumar Maithel · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗
19. Robert C.G. Martin · 1 shared paper, 2025 · strength 0.19
    • Paper Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2025.07.017↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.